Rad
Breast MRI
search
Breast MRI
, Magnetic Resonance Imaging of the Breast
Indications
Breast Cancer Screening
in high risk women
BRCA1
or
BRCA2
genetic mutation
First degree relative with
BRCA1
or
BRCA2
Radiation exposure to chest under age 30 years
Lifetime
Breast Cancer
risk estimated >20%
Other
Genetic Syndrome
s (and an affected 1d relative)
Li-Fraumeni Syndrome
Cowden syndrome
Bannayan-Riley-Ruvalcaba Syndrome
References
Saslow (2007) CA Cancer J Clin 57: 75-89 [PubMed]
Breast Cancer
evaluation
Define extent of
Breast Cancer
index lesion
Identify concurrent cancer in contralateral
Breast
Assess response to
Chemotherapy
Define new
Breast Cancer
s in those with implants
Assess for suspected residual cancer post-surgery
Inconclusive
Mammogram
, breast
Ultrasound
, CBE
References
Silverstein (2005) J Am Coll Surg 201:586-97 [PubMed]
Protocol
Breast Cancer Screening
Annual Breast MRI starting at age 30 in high risk women (for indications as above)
Continue
Mammogram
s and
Clinical Breast Exam
s
Efficacy
Breast Cancer Screening
Test Sensitivity
: 79% (
Mammogram
: as low as 33%)
Test Specificity
: 90% (
Mammogram
: 95%)
Higher risk of
False Positive
s than
Mammogram
References
Kriege (2004) N Engl J Med 351:427-37 [PubMed]
Kuhl (2005) J Clin Oncol 23:8469-76 [PubMed]
Disadvantages
Breast Cancer Screening
Too expensive for general population screening
Twice the
False Positive Rate
(10%) compared with
Mammogram
(5%)
Would substantially increase unnecessary testing if MRI applied to general population screening
Resources
Breast Cancer
Risk Assessment Tool
https://bcrisktool.cancer.gov/
References
Salzman (2019) Am Fam Physician 99(8): 505-14 [PubMed]
Type your search phrase here